More on ardx
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.00 |
|
|||
| Open | $3.01 | ||||
| 52 Wk High | $20.98 | ||||
| 52 Wk Low | $6.36 | ||||
| Day High | $3.04 | ||||
| Day Low | $2.98 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,743,956 | ||||
- Ardelyx presents real-world Xphozah phosphate data at ASN 2026
- Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders
- Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
- Ardelyx data shows fewer doctor visits after IBS-C drug initiation
- Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
- Ardelyx to present three posters at ASN Kidney Week 2026
- Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
- Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Ardelyx, Inc. (ARDX)
- Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards
- Ardelyx to Participate in Upcoming Investor Conferences
Entities mentioned with ARDX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
